Literature DB >> 9603610

Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder.

Z Wang1, J Valdes, R Noyes, T Zoega, R R Crowe.   

Abstract

We searched for mutations in the CCK gene in panic disorder with single-strand conformational polymorphism (SSCP) analysis of the three exons and promotor region of the gene. We found a C-->T transition at position -36 (CCK(-36C-->T)) in a GC box, a binding site for transcription factor Sp1, in the promotor region. The allele frequency was 0.168 (95% CI, 0.116-0.221) in 98 persons with panic disorder and 0.083 (95% CI, 0.059-0.107) in 247 geographically matched, unscreened controls. A transmission disequilibrium test based on panic disorder as the affected phenotype was nonsignificant (chi2 = 0.93), but when panic disorder or attacks were considered as affected, statistically significant transmission disequilibrium was detected (chi2 = 4.00, P < 0.05). Linkage analysis was uninformative. In exploratory analyses to search for clinical correlations, the "T" allele was found in 59% of 22 persons with panic attacks but not panic disorder, compared with 31% of those who met the criteria for panic disorder. An association between the CCK polymorphism and panic disorder cannot be considered established due to the inconsistencies in the results noted above, but if the provisional association can be replicated, the findings are consistent with CCK(-36C-->T) being a disease-susceptibility allele that alone is neither necessary nor sufficient to cause panic disorder but that increases vulnerability by acting epistatically.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603610     DOI: 10.1002/(sici)1096-8628(19980508)81:3<228::aid-ajmg5>3.0.co;2-s

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

Review 1.  The genetics of panic disorder.

Authors:  C T Finn; J W Smoller
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

Review 2.  Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.

Authors:  A S Howe; H N Buttenschøn; A Bani-Fatemi; E Maron; T Otowa; A Erhardt; E B Binder; N O Gregersen; O Mors; D P Woldbye; K Domschke; A Reif; J Shlik; S Kõks; Y Kawamura; A Miyashita; R Kuwano; K Tokunaga; H Tanii; J W Smoller; T Sasaki; D Koszycki; V De Luca
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

Review 3.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

4.  Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon.

Authors:  Clyde W Hodge; Jacob Raber; Thomas McMahon; Helen Walter; Ana Maria Sanchez-Perez; M Foster Olive; Kristin Mehmert; A Leslie Morrow; Robert O Messing
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 5.  Gastrin: old hormone, new functions.

Authors:  Graham Dockray; Rod Dimaline; Andrea Varro
Journal:  Pflugers Arch       Date:  2004-10-05       Impact factor: 3.657

Review 6.  The genetic basis of panic disorder.

Authors:  Hae-Ran Na; Eun-Ho Kang; Jae-Hon Lee; Bum-Hee Yu
Journal:  J Korean Med Sci       Date:  2011-05-18       Impact factor: 2.153

7.  Some Metatheoretical Principles for Personality Neuroscience.

Authors:  Neil McNaughton; Luke D Smillie
Journal:  Personal Neurosci       Date:  2018-08-10

8.  The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders.

Authors:  Jocelien D A Olivier; Christiaan H Vinkers; Berend Olivier
Journal:  Front Pharmacol       Date:  2013-06-11       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.